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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPERConsensus Statement on the Deﬁnition of On-Treatment Platelet Reactivity 2261
Udaya S. Tantry, Laurent Bonello, Daniel Aradi, Matthew J. Price, Young-Hoon Jeong,
Dominick J. Angiolillo, Gregg W. Stone, Nick Curzen, Tobias Geisler, Jurrien ten Berg, Ajay Kirtane,
Jolanta Siller-Matula, Elisabeth Mahla, Richard C. Becker, Deepak L. Bhatt, Ron Waksman,
Sunil V. Rao, Dimitrios Alexopoulos, Rossella Marcucci, Jean-Luc Reny, Dietmar Trenk, Dirk Sibbing,
Paul A. Gurbel, for the Working Group on On-Treatment Platelet Reactivity
Although platelet function testing (PFT) has been incorporated into the updated American
and European practice guidelines to facilitate the choice of P2Y12 receptor inhibitor in
selected high-risk patients treated with percutaneous coronary intervention, routine testing is
not recommended (Class III). Recent prospective randomized trials of PFT did not
demonstrate clinical beneﬁt of this strategy. Recent data also suggests that low on-treatment
platelet reactivity is associated with a higher risk of bleeding. In this updated consensus
document, Tantry and colleagues review the available evidence addressing the relation of
platelet reactivity to thrombotic and bleeding events and propose cutoff values for high and
low platelet reactivity that might be used in future investigations of personalized antiplatelet
therapy.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGYPatient and Hospital Characteristics Associated With Inappropriate PCI 2274
Paul S. Chan, Sunil V. Rao, Deepak L. Bhatt, John S. Rumsfeld, Hitinder S. Gurm,
Brahmajee K. Nallamothu, Matthew A. Cavender, Kevin F. Kennedy, John A. Spertus
Chan and colleagues analyzed data from the National Cardiovascular Data Registry
CathPCI Registry to determine whether certain patient demographics and/or insurance
statuses are associated with the rate of inappropriate percutaneous coronary intervention
(PCI). The appropriateness of PCI was determined using appropriate use criteria for over
200,000 patients; 12% were classiﬁed as inappropriate. After multivariable adjustment, male
and white patients were more likely to undergo an inappropriate PCI. Compared with
privately-insured patients, those with Medicare, other public insurance, and no insurance
were less likely to undergo an inappropriate PCI. These results suggest that previous research
showing lower rates of PCI in women and minorities may not represent underuse, but rather
less inappropriate use.
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Benjamin R. Szwejkowski, Stephen J. Gandy, Sushma Rekhraj, John G. Houston, Chim C. Lang,
Andrew D. Morris, Jacob George, Allan D. Struthers
Szwejkowski and colleagues performed a randomized, double-blind trial to ascertain whether
high-dose allopurinol regresses left ventricular mass (LVM) in patients with type 2 diabetes
mellitus and left ventricular hypertrophy (LVH). Allopurinol 600 mg/day or placebo was
given for 9 months. Allopurinol signiﬁcantly reduced absolute LVM and LVM indexed to
body surface area, as calculated by cardiac magnetic resonance imaging. The authors speculate
that allopurinol reduces oxidative stress in the ventricle and that this is the mechanism for the
reduction in LVM.
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Sherman J. Bigornia, Melissa G. Farb, Stephanie Tiwari, Shakun Karki, Naomi M. Hamburg,
Joseph A. Vita, Donald T. Hess, Michael P. LaValley, Caroline M. Apovian, Noyan Gokce
Bigornia and colleagues studied whether the effects of weight loss on arterial function are
modiﬁed by insulin levels. Plasma metabolic parameters and vascular endothelial function
were assessed at baseline and following weight loss intervention in obese and overweight
individuals. In individuals with higher baseline plasma insulin levels, >10% weight loss
(compared with <10%) signiﬁcantly improved brachial artery macrovascular ﬂow-mediated
vasodilation and microvascular reactive hyperemia. In contrast, vascular function did not
change signiﬁcantly in the lower insulin group despite a similar degree of weight loss.
These ﬁndings suggest that reversal of insulin resistance and endothelial dysfunction may be
mechanistically intertwined.
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Alanna A. Morris, Robert T. Cole, Emir Veledar, Naveen Bellam, S. Raja Laskar,
Andrew L. Smith, Howard M. Gebel, Robert A. Bray, Javed Butler
Panel reactive antibody (PRA) screening is used to determine the presence of pre-formed
antibodies to population-wide human leukocyte antigens. Patients with higher PRA values
tend to have extended waiting times while listed for solid organ transplant. Morris and
colleagues reviewed information in the Organ Procurement and Transplantation database to
study whether race or ethnicity affect PRA levels. Blacks had a higher peak PRA than all
other groups and were more likely to be sensitized. Black heart transplant recipients were
more likely to experience graft failure than Hispanic, white, or Asian recipients. These results
show that race/ethnicity and level of sensitization are important predictors of graft survival.
Editorial Comment: Sean P. Pinney, p. 2316HEART RHYTHM DISORDERSPulmonary Vein Isolation and Autonomic Denervation 2318Demosthenes G. Katritsis, Evgeny Pokushalov, Alexander Romanov, Eleftherios Giazitzoglou,
George C. M. Siontis, Sunny S. Po, A. John Camm, John P. A. Ioannidis
Katritsis and colleagues investigated whether the combination of conventional pulmonary
vein isolation (PVI) and ganglionated plexi (GP) modiﬁcation in a single ablation procedure
yields higher success rates than PVI or GP ablation alone. A total of 242 patients with
symptomatic paroxysmal atrial ﬁbrillation (PAF) were recruited and randomized to either
circumferential PVI, anatomic ablation of the main right and left atrial GP, or circumferential
PVI followed by anatomic ablation of the 4 major atrial GP. Freedom from atrial ﬁbrillation
or other sustained atrial tachycardia was higher in the PVI+GP group. Addition of GP
ablation to PVI confers a signiﬁcantly higher success rate compared with either PVI or GP
alone in patients with PAF.
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Marie-Annick Clavel, David Messika-Zeitoun, Philippe Pibarot, Shivani R. Aggarwal,
Joseph Malouf, Phillip A. Araoz, Hector I. Michelena, Caroline Cueff, Eric Larose, Romain Capoulade,
Alec Vahanian, Maurice Enriquez-Sarano
Clavel and colleagues hypothesized that the extent of aortic valve calciﬁcation (AVC)
detected by multidetector computed tomography (MDCT) would correlate with the severity
of aortic valve stenosis using Doppler echocardiography. A total of 646 patients with aortic
stenosis (AS) underwent Doppler echocardiography and AVC measurement by MDCT.
Mean transvalvular gradient (MG) was independently and strongly inﬂuenced by AVC.
Among patients with AS, MG is often discordant from aortic valve area (AVA). The authors
speculate that adding AVC may help to determine the severity of AS when there are
discrepancies between MG and AVA.
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